We report the identification of a photocleavable anionic surfactant, 4-hexylphenylazosulfonate (Azo), which can be rapidly degraded by ultraviolet irradiation, for top-down proteomics. Azo can effectively solubilize proteins with performance comparable to that of sodium dodecyl sulfate (SDS) and is compatible with mass spectrometry. Azo-aided topdown proteomics enables the solubilization of membrane proteins for comprehensive characterization of post-translational modifications. Moreover, Azo is simple to synthesize and can be used as a general SDS replacement in SDS-polyacrylamide gel electrophoresis.
A comprehensive analysis of 'proteoforms' that arise from genetic variations and post-translational modifications (PTMs) is essential for deciphering biological systems at a functional level 1 . The conventional 'bottom-up' proteomics analyzes peptides from protein digests, which does not directly identify proteoforms and is suboptimal for characterizing PTMs and sequence variants 1 . By contrast, top-down mass spectrometry (MS)-based proteomics analyzes intact proteins and is the most powerful method to comprehensively characterize proteoforms deciphering the PTMs together with sequence variations [1] [2] [3] . However, despite its promise, top-down proteomics still faces major challenges 4 . One challenge in top-down proteomics is protein solubility 4 , especially for membrane proteins, which constitute a large proportion of the proteome, play a critical role in many cellular functions and are important drug targets 5, 6 . To effectively extract proteins from cells or tissues, surfactants (also known as detergents) are commonly included in the extraction buffer 6 . Unfortunately, conventional ionic surfactants are not compatible with MS because they greatly suppress protein MS signal 6, 7 . Therefore, surfactants need to be removed before MS analysis, which may result in protein loss and degradation 8, 9 . Developing MS-compatible surfactants that can be quickly degraded into innocuous non-surfactant byproducts before MS analysis can help address the protein solubility challenge in top-down proteomics. Efforts have been made in developing various acid-labile surfactants, which have been effective for bottom-up proteomics [10] [11] [12] [13] ; however, none have demonstrated direct compatibility with intact protein MS for top-down proteomics.
Here we evaluated photocleavable surfactants by inserting a photocleavable moiety in between the surfactant hydrophilic head and hydrophobic tail that can be rapidly cleaved and degraded upon ultraviolet (UV) irradiation before MS analysis (Fig. 1a) . Degradation via a photochemical reaction has the advantages of being simple and fast, and one can easily control it by turning a UV lamp on and off [14] [15] [16] . Our goal was to identify a strong photocleavable surfactant that can effectively solubilize proteins during sample preparation with performance similar to that of sodium dodecyl sulfate (SDS) 8 , but which is also compatible with topdown proteomics.
We performed a systematic screening of many synthesized candidates (Supplementary Notes 1-3 and Supplementary Table 1 ) and identified 4-hexylphenylazosulfonate 17 ( Fig. 1b and Supplementary Figs. 1-2), hereinafter referred to as ' Azo' , as the top-performing surfactant, as it not only is water soluble, but also greatly improves protein extraction (Supplementary Table 1 ). Notably, Azo was simple to synthesize, requiring only two steps (Fig. 1c) , and could be effectively purified by recrystallization, making it an ideal candidate for general use as a surfactant in biochemical applications. For instance, we have used Azo instead of SDS to perform polyacrylamide gel electrophoresis (PAGE) ( Supplementary Fig. 3 ), demonstrating that Azo could be used as an SDS replacement in SDS-PAGE.
We further investigated the photodegradation kinetics of the Azo dissociating into 4-hexylphenol, 4-hexylbenzene, nitrogen and hydrogen sulfate 14 ( Fig. 1b) upon irradiation with a 100-W highpressure mercury lamp for 0, 10, 30, 60, 90 and 120 s using UV-vis spectroscopy (Fig. 1d) . By comparing several degradation conditions, we found that the presence of organic solvent and acid facilitates rapid degradation of Azo ( Supplementary Fig. 4 ).
Next, we examined the efficacy of Azo for solubilizing proteins from cardiac tissues using a direct side-by-side comparison with SDS, and its acid-labile mimic, MS-compatible slowly degradable surfactant (MaSDeS) 10 , as well as n-dodecyl-β-d-maltoside (DDM), a commonly used surfactant for native MS 18 . The SDS-PAGE gel (Fig. 1e ) and protein assay (Fig. 1f) show that the addition of 0.5% Azo to the extraction buffer, labeled as E3(Azo), drastically improved the solubilization of proteins when compared with the control without surfactant, E3(NS), which barely solubilized proteins after the depletion of soluble proteins using HEPES buffer, E1 and E2. Overall, the anionic surfactants, Azo, SDS and MaSDeS, are highly effective in solubilizing proteins compared with the nonionic surfactant, DDM (Fig. 1e,f) . Furthermore, a western blot analysis confirmed the presence of common cardiac membrane proteins in E3(Azo), demonstrating the successful extraction of integral membrane proteins by Azo ( Supplementary Fig. 5 ).
More important, Azo surfactant is MS-compatible. We first performed direct infusion electrospray ionization (ESI)-MS analysis using ubiquitin (Ubi) in the presence of 0.1% of a chosen surfactant, without an additional desalting step (Fig. 1g) Table 2 ) with collision-induced dissociation (CID). Water-insoluble cardiac tissue pellets were extracted with 25 mM NH 4 HCO 3 buffer containing either 0.5% Azo (E3(Azo)) or no surfactant (E3(NS)) ( Supplementary Fig. 13a ). Notably, both the SDS-PAGE gel (Fig. 1e ) and the total ion current ( Supplementary Fig. 13b ) showed significant increases in protein concentration and MS signal, respectively, with the use of Azo when compared with no surfactant. In a single RPLC-MS run, we observed 663 unique proteoforms in E3(Azo), in contrast to E3(NS), where only six unique proteoforms were detected ( Supplementary Fig. 13c,d and Supplementary Table 2 ). Moreover, we detected a total of 2,836 proteoforms on the basis of accurate mass measurements (Supplementary Table 3 ) from the combination of three liquid chromatography (LC)-MS runs, among which 388 proteoforms were identified on the basis of one-dimensional online RPLC-MS/MS data (Supplementary Table 4) representing 171 proteins (Supplementary Table 5 ) from mitochondria, nucleus, plasma membrane, cytoskeleton, endoplasmic reticulum, cytoplasm and extracellular region ( Supplementary Fig. 13e ,f and Supplementary Note 6).
We observed various PTMs, including acetylation, methylation, phosphorylation and palmitoylation (Supplementary Tables  5-10 ). Azo also greatly improved the depth of the detection and revealed many proteins that were undetectable in the control sample ( Supplementary Fig. 14) . For example, Azo enabled the detection and identification of multiple proteoforms of an important Z-disk protein, calsarcin-1 ( Supplementary Fig. 14d ).
We further showed that Azo can effectively extract and enable the top-down proteomic analysis of membrane proteins from cardiac tissues ( Fig. 2 and Supplementary Fig. 15 ), as well as human embryonic kidney (HEK293T) cells (Supplementary Fig. 16 and Supplementary  Tables 9 and 10 ). Under the optimal UV-degradation conditions (which include organic solvent at low pH), many hydrophobic proteins were soluble after Azo degradation. Using cardiac tissue as an example, we identified several important integral membrane proteins such as phospholamban (PLN), receptor-expressing enhancing protein, and succinate dehydrogenase cytochrome b560 with one, two and three transmembrane domains (TMDs), respectively 
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NAture MethoDS (Fig. 2a,b and Supplementary Fig. 17 ). Notably, we detected not only intact unmodified PLN, but also its highly abundant palmitoylated proteoform (Fig. 2a) . We confidently localized the palmitoylation modification to cysteine 36 within the transmembrane region on the basis of the unmodified b 33 ion and the palmitoylated b 38 ion ( Fig. 2a and Supplementary Fig. 18 ). PLN is a well-known cardiac regulatory protein that has been implicated in cardiomyopathy 19 . Similarly, we have characterized receptor-expressing enhancing protein and localized an acetylation site to the N-terminus (Fig. 2b) .
Moreover, we confidently identified 46 subunits of the electron transport chain (Supplementary Table 6 ) and 51 proteins with TMDs (Supplementary Table 7 ) directly from cardiac tissue. Notably, all the subunits of the endogenous ATP synthase complex were identified with high mass accuracy (Fig. 2c) . This enzyme, which plays a critical role in biological energy metabolism 20 , includes a domain located in the inner mitochondrial membrane (e, f, g, ATP6, ATP8, DAPIT, c and 6.8PL), as well as a domain in the mitochondrial matrix (α, β, b, ε, δ, OCSP, F 6 , d and γ). In particular, Azo facilitated the identification of ATP6 (also known as ATP synthase subunit a) with six TMDs, as well as the localization of a trimethylation to lysine 43 between two TMDs of ATP synthase subunit c (Supplementary Fig. 19 ). Besides the small and intermediate size subunits (<30 kDa), with the use of Azo, we were able to detect and identify the high-molecular-weight (>50 kDa) ATP synthase subunits: ATP synthase α and β (Fig. 2c) . We observed highly efficient CID fragmentation, which preferentially cleaved in the transmembrane domain portions of the proteins (Fig. 2a,b and Supplementary Figs. 17-19 ), leading to confident protein identification of these integral membrane proteins and localization of PTMs in online RPLC-MS/MS experiments (Supplementary Tables 4-10). Thus, Azo enables the detection and comprehensive characterization of these important cardiac membrane protein complexes, which opens up new opportunities to uncover their molecular basis in health and disease.
In summary, we report the application of a photocleavable MS-compatible surfactant to increase protein solubility for highthroughput top-down proteomics. Among all the surfactants we evaluated, we found Azo to be the only strong surfactant capable of effectively solubilizing proteins, including membrane proteins, without hindering downstream top-down MS analysis. Azo has the potential to further enhance top-down global proteomics when coupled to multidimensional separation, complementary fragmentation techniques and improved data acquisition strategies 4 (Supplementary Note 6). We expect that Azo will facilitate a myriad of proteomic studies for understanding disease mechanisms and clinical diagnosis. Given the instrumental roles of surfactants in biochemical research, we envision that this photocleavable surfactant will have a broader impact beyond proteomics. Notably, , sucrose, sodium fluoride (NaF), phenylmethanesulfonyl fluoride (PMSF), EDTA, DDM, octyl-β-d-glucopyranoside (OG), SDS, digitonin (DGT), protease inhibitor cocktail, tri(2-carboxyethyl) phosphine hydrochloride (TCEP), dithiothreitol (DTT), 2-mercaptoethanol (2-ME), β-casein from bovine milk, Ubi from bovine erythrocytes, bovine serum albumin (BSA), myoglobin from equine heart and cytochrome c (Cytc) from equine heart, ribonuclease A (RNase A) and RNase B from bovine pancreas were purchased from SigmaAldrich. ProteaseMax (PM) 21 was obtained from Promega. RapiGest (RG, also known as ALS) 11, 13 was purchased from Waters. Sodium orthovanadate, HPLCgrade H 2 O, acetonitrile (ACN), methanol, ethanol, optima LC-MS-grade formic acid, optima LC-MS-grade isopropanol (IPA), Pierce protein-free Tris-buffered saline (TBS) blocking buffer, Tween 20 and molecular weight cutoff (MWCO) (10 and 30 kDa MWCO) (0.5 ml) centrifugal filters, Coomassie blue R-250 and Dulbecco's modified Eagle's medium (DMEM) were purchased from Fisher Scientific. Goat anti-antigen rabbit IgG (H + L), goat anti-antigen mouse IgG (H + L), BCA protein assay and Pierce 660 nm Protein Assay Reagent, Ionic Detergent Compatibility Reagent were purchased from Thermo Fisher. Protein Assay Dye Reagent Concentrate was purchased from Bio-Rad. Voltage-dependent anion-selective channel antibody was purchased from Biovision. Mitochondrial import receptor subunit (TOM20) was purchased from Santa Cruz Biotechnology. Sodium potassium adenosine triphosphate (Na-K ATPase) and cadherin antibodies were purchased from Abcam. Phospholamban antibody was purchased from Bioss. Fetal bovine serum was purchased from Life Technologies. Mini-gels (12.5%) for SDS-PAGE were prepared in-house using acrylamide/bis-acrylamide (37.5:1) 40% solution purchased from Hoefer. MS-compatible degradable surfactant (MaSDeS) was synthesized by Promega as described previously 10 and provided to us as a gift.
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Synthesis of O-nitrobenzyl surfactant family. Synthesis of 4-(hydroxyethyl)-3-nitrobenzoic acid.
A solution of 500 mg of 4-(bromomethyl)-3-nitrobenzoic acid (1.92 mmol) and 814 mg of Na 2 CO 3 (7.68 mmol) in 16 ml of a mixture of H 2 O/ acetone 1:1 (v/v) was refluxed for 5 h. The acetone was then evaporated and the resulting solution was washed with 9 ml of diethyl ether. After the wash, the solution was acidified with 18% hydrochloric acid until a precipitate was observed. The product was then extracted with ethyl acetate (3 × 12 ml). The concentrated organic layer was washed with H 2 O (6 ml) and dried over MgSO 4 . The dry organic layer was filtered and concentrated in vacuo to yield 74% of 4-(hydroxyethyl)-3-nitrobenzoic acid as a yellow solid 22 .
Synthesis of intermediate product I (C12).
Using a traditional EDC coupling, 270 mg of 4-(hydroxyethyl)-3-nitrobenzoic acid (1.37 mmol) was reacted with 0.32 ml of dodecylamine (1.37 mmol) to produce intermediate product I (n = 10, C12) in a 44% yield. See also Supplementary Note 1.
Synthesis of intermediate product I (C8).
Using a traditional EDC coupling, 300 mg of 4-(hydroxyethyl)-3-nitrobenzoic acid (1.52 mmol) was reacted with 0.25 ml of octylamine (1.37 mmol) to produce intermediate product I (n = 6, C8) in a 19% yield. See also Supplementary Note 1.
Synthesis of intermediate product I (C6).
Using a traditional EDC coupling, 300 mg of 4-(hydroxyethyl)-3-nitrobenzoic acid (1.52 mmol) was reacted with 0.20 ml of hexylamine (1.37 mmol) to produce intermediate product I (n = 4, C6) in a 46% yield. See also Supplementary Note 1.
Synthesis of intermediate product IIs.
Each intermediate product I (7.7 mmol) was dissolved in 40 ml of THF, and the solution was cooled to 0 °C. While the solution was stirred, 4-nitrophenyl-chloroformate was slowly added to the THF solution. Then 0.16 ml of pyridine was added dropwise over 20 min and the reaction was stirred for an additional 2 h. The reaction was then filtered. The final product was purified using a silica column that was packed using a solvent of 7:3 ration of
Synthesis of O-nitrobenzyl final product.
Intermediate product II (0.13 mmol) was dissolved in 2.3 ml of THF. In a separate container, 0.2 mmol of 3-aminopropane sulfonic acid sodium salt in 0.43 ml of water was added to the THF solution. The reaction was stirred overnight at 50 °C. The product was purified using a silica column with a mixture of dichloromethane:methanol (1:5). The final product was confirmed by ESI-MS. ESI mass spectra for the synthesized ligand molecules were obtained using a Waters (Micromass) LCT mass spectrometer. O-nitrobenzyl (ONB) C12 (C 24 Synthesis of O-nitroveratryl surfactant family. The O-nitroveratryl (ONV) surfactants were synthesized according to previously reported procedures 15 . In brief, to a solution of Fmoc-ONV-COOH (0.57 mmol) and HBTU (0.69 mmol) in 3.5 ml of anhydrous DMF, N-ethyldiisopropylamine (1.2 mmol) was added dropwise. The solution was cooled on ice and added to a solution of dodecylamine in 0.5 ml of ice-cold ethanol. After stirring for 30 min at 0 °C, the mixture was stirred overnight at room temperature. The resulting precipitate was filtered and washed with DMF and then subjected to in vacuo drying. Intermediate product 1 (n = 10, C12) was obtained as an amorphous white powder. Similar procedures were followed for n = 8, C10 and n = 6, C8. See also Supplementary Note 2.
Synthesis of NH 2 -ONV-CH 2 (CH 2 ) n CH 3 (intermediate product II).
Piperidine was added dropwise to a solution of intermediate product I (0.6 mmol) in anhydrous DMF (3 ml) to reach a final concentration of 2 M. The solution was stirred at room temperature for 2 h, and then DMF was removed by evaporation. The residual was dissolved in methanol, and the resulting precipitate was removed by filtration. A pale yellow solid was obtained after evaporation of the filtered solution. See also Supplementary Note 2. Synthesis of the azobenzene surfactant family. The azobenzene surfactant family was synthesized according to similar procedures as previously described 24 . Specifically, 4 mmol of 4-n-hexylaniline (n = 4, C6) was stirred in a mixture of 4.8 ml of 10% hydrochloric acid and 8 ml of deionized H 2 O. Then 4 mmol of NaNO 2 dissolved in 4 ml of cold water was added dropwise to this solution. During the addition of the NaNO 2 , the solution was cooled to 10 °C. After the addition was completed (15 min), the solution was stirred for an additional 15 min at 5 °C. A similar procedure was carried out for 4-n-octylaniline (n = 6, C8). For 4-ndecylaniline (n = 8, C10) and 4-n-dodecylaniline (n = 10, C10), the solution of 4-n-alkylaniline was heated to 70 °C and then cooled in an ice bath to 10 °C under vigorous stirring. NaNO 2 was added dropwise starting at 20 °C and concluded at 10 °C, after which the solution was stirred for 15 min at 5 °C. For the coupling reaction, the freshly prepared diazonium salt was filtered into a stirred and cooled solution (temperature = 5-10 °C) of 8 mmol of Na 2 SO 3 and 12 mmol of Na 2 CO 3 in 20 ml of deionized H 2 O. To complete the precipitation of the surfactant, the solution was refrigerated at 4 °C overnight. The yellow compounds were purified by recrystallization with a yield of about 50%, and no impurities were detected by NMR. We made surfactant solutions by gently heating the surfactant at 37 °C and then bringing it to room temperature after no solid remained. The working concentration was 0.5%-1% in 25 mM NH 4 HCO 3. Kraft temperature (a clear 1% surfactant solution) was previously reported at 24.5 °C (ref. 24 ). A high-resolution mass spectrum of azobenzene (C6), referred to as Azo ( Supplementary Fig. 1 ), was taken as follows: a solution of 1% Azo in 25 mM NH 4 HCO 3 was diluted 1:100 in ACN (0.3% NH 4 OH). The sample was directly injected into a 7 T linear ion trap/Fourier transform ion cyclotron resonance mass spectrometer (LTQ/FT Ultra, Thermo Scientific) with a nano-ESI source (Triversa NanoMate; Advion Bioscience). A voltage of −1.4 kV was applied with 0.3 psi drying gas. Fifty scans were averaged with five microscans in a scan. The mass range was set from 100 to 500 m/z. ESI-MS for Azo (C 12 
Synthesis of sulfonate-ONV-CH 2 (CH 2 ) n CH 3 (final product
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(2 H, m,-Ar-CH 2 ), 1.61 (2 H, t, -Ar-CH 2 CH 2 ), 1.28 (6 H, t, -(CH 2 ) 3 ), 0.086 (3 H, t, -(CH 2 ) 3 -CH 3 ). See also Supplementary Note 3.
Tissue handling. Swine hearts were excised from healthy Yorkshire domestic pigs, snap-frozen in liquid N 2 , and stored under −80 °C before use. All homogenization and centrifugation steps were performed at 4 °C.
Protein extraction and LC-MS analysis of cardiac tissue.
The frozen tissue samples (approximately 500 mg) were cut into small pieces and washed with PBS buffer containing protease inhibitors and reducing agent (5 mM DTT, 1 mM PMSF, 1× protease inhibitor cocktail). The tissue was then homogenized in HEPES buffer with both protease and phosphatase inhibitors (25 mM HEPES, 250 mM sucrose, 50 mM NaF, 1 mM PMSF, 2.5 mM EDTA, 1 mM Na 3 VO 4 , 1 mM PMSF, 5 mM DTT, 1× protease inhibitor cocktail) with a Polytron electric homogenizer (model PRO200, Pro scientific) set to the lowest speed as described previously 10 . The homogenate was centrifuged at 211,750g using Beckman Ultracentrifuge and a Ti-80 rotor for 1 h. The supernatant after the first HEPES extraction was removed and saved as 'E1' extraction. The HEPES extraction was repeated on the resulting pellet and saved as 'E2' . After the second HEPES extraction, the tissue pellet was suspended in 25 mM NH 4 HCO 3 and evenly divided into smaller aliquots. In one aliquot, 25 mM NH 4 HCO 3 buffer with no surfactant serving as controls was used in a 1:1 ratio (homogenate:buffer) and labeled as 'E3(NS)' following incubation and centrifugation. In the other aliquots, surfactants (1% in 25 mM NH 4 HCO 3 ) were individually added to the other aliquots in a 1:1 ratio (homogenate:surfactant) and labeled as 'E3(Surfactant)' following incubation and centrifugation. Protein assays were performed using Pierce 660 nm Protein Assay Reagent with Ionic Detergent Compatibility Reagent (https://www.thermofisher.com/order/catalog/ product/22660) for data presented in Fig. 1f and BCA protein assay (with 5% SDS compatible) for data presented in Supplementary Fig. 10 .
RPLC was performed with a nanoACQUITY M-Class ultra-performance liquid chromatography system (Waters). Mobile phase A contained 0. 
SDS-PAGE comparing Azo with SDS, DDM and
MaSDeS. An equal volume (7 µl) of each extraction was subsequently resolved using 12.5% SDS-PAGE with a voltage of 50 V for 30 min and 120 V for approximately 75 min. Proteins were visualized using Coomassie Brilliant Blue R-250. The methods described here correspond to data presented to Fig. 1e .
Western blot comparing Azo with SDS, DDM and MaSDeS. Equal volumes of tissue lysate (10 µl) were loaded and resolved on 12.5% SDS-PAGE gels. Proteins were transferred to a polyvinylidene difluoride membrane, fast semi-dry blotter (Fisher Scientific), using 20 V for 12 h at 4 °C. The membrane was placed in a protein-free blocking buffer (Fisher Scientific) for 1 h at room temperature and incubated with primary antibodies for 1.5 h at room temperature. The membranes were then washed with TBS with 0.1% Tween five times before incubation with the secondary antibodies for 1.5 h (room temperature). After five washes with TBS with 0.1% Tween, the membranes were developed using enhanced chemiluminescence detection (Fisher Scientific). The methods described here correspond to data presented in Supplementary Fig. 5 .
Comparison of the top-down MS compatibility of Azo with SDS, DDM and
MaSDeS. Ubi was dissolved in a buffer containing 80:5:5:10 IPA:H 2 O:formic acid:1% surfactant (Azo, SDS, DDM or MaSDeS) with 10 mM DTT. The Azo sample was irradiated for 3 min. The MaSDeS sample was degraded for 24 h at room temperature. The samples were then directly injected into a 7 T linear ion trap/Fourier transform ion cyclotron resonance mass spectrometer (LTQ/FT Ultra, Thermo Scientific) with a nano-ESI sprayer (TriVersa NanoMate; Advion Bioscience). A voltage of 1.4 kV versus the inlet was applied with 0.3 psi drying gas. Fifty scans were collected with five microscans in one scan. The mass range was set from 600 to 2,000 m/z. The methods described here correspond to data presented in Fig. 1g .
Protein extraction and LC-MS analysis of sarcoplasmic reticulum and mitochondria enrichment from cardiac tissue. After around 170 mg of tissue had been cut into small pieces, the tissue was homogenized in HEPES buffer containing both protease and phosphatase inhibitors (50 mM HEPES, 0.6 M KCl, 250 mM sucrose, 500 mM NaF, 1 mM PMSF, 2 mM EDTA, 1 mM Na 3 VO 4 , 5 mM DTT, 25 µg ml DGT, 1× protease inhibitor cocktail) with a Polytron electric homogenizer set to the lowest speed (tissue) to deplete soluble proteins as described previously 25 . The homogenate was centrifuged at 20,000g using a Thermo Scientific Legend Micro 21R Ultracentrifuge. The supernatant was removed and labeled as 'E1' . The pellet was suspended in the buffer (25 mM NH 4 HCO 3 , 500 mM NaF, 1 mM PMSF, 2 mM EDTA, 1 mM Na 3 VO 3 , 5 mM DTT, 25 µg mL DGT, 1× protease inhibitor cocktail) to remove residual proteins and labeled as 'E2' . The resulting tissue pellet was suspended in 25 mM NH 4 HCO 3 and evenly divided into smaller aliquots, centrifuged at 20,000g, and the supernatant was removed. NH 4 HCO 3 buffer (25 mM) or 1% Azo in 25 mM NH 4 HCO 3 was added to the aliquots. After homogenization and incubation, the samples were centrifuged and the supernatant was collected.
Enriched sarcoplasmic reticulum (50 µl) and mitochondria lysate from cardiac tissue was diluted with 440 µl of 50:48. Protein extraction and LC-MS analysis of endoplasmic reticulum and mitochondria enriched lysate from HEK293T cells. Cells were grown on 10 cm plates in DMEM with 10% fetal bovine serum and 1× penicillin/streptomycin solution at 37 °C and 5% CO 2 . Cells from two 10 cm plates were washed twice with PBS and lysed in 500 µl of buffer (10 mM Tris, 2 mM DTT, 1 mM PMSF, 50 µg ml DGT, 1× protease inhibitor cocktail) using 50 strokes with dounce homogenizer followed by five passages through a 27-gauge needle. Cells were then incubated for 10 min on ice, evenly divided into two aliquots and centrifuged at 1,000g (4 °C) to remove unbroken cells and the nuclei. The supernatant was mixed with 0.5 ml of sucrose (50%) and centrifuged at 21,000g (4 °C). The pellet was washed with 1 ml of NH 4 HCO 3 (E2). Finally, the pellets were dissolved in 100 µl of Azo (0.5% in 25 mM NH 4 HCO 3 ) or 100 µl of 25 mM NH 4 HCO 3 without surfactant serving as controls.
Enriched endoplasmic reticulum (50 µl) and mitochondria lysate from HEK293T cells was diluted with 400 µl of 50% IPA:49% H 2 O:1% formic acid and 50 µl of TCEP (1 M). The sample was irradiated for 3 min, then concentrated and exchanged into 10:10:80 ACN:IPA:1% formic acid in H 2 O with a 10 kDa MWCO centrifugal filter. Proteins were separated using the following gradient: 0-5 min, 20% B; 5-65 min, 20-95% B; 65-75 min, 95% B; 75-76 min, 20% B; 76-80 min, 20% B. Column temperature was 50 °C. The methods described here correspond to data presented in Supplementary Fig. 16 and Supplementary Tables 9 and 10 .
Azo PAGE and SDS-PAGE comparison. Resolving gel was made using 1.62 ml water, 2.09 ml acrylamide, 1.25 ml Tris-base (1.5 M, pH 8.8), 0.05 APS (10%) and 0.002 ml tetramethylethylenediamine. Stacking layer was made using 1.42 ml water, 0.33 ml acrylamide, Tris-base (1 M, pH 6.8), 0.02 APS (10%) and 0.002 ml tetramethylethylenediamineTEMED. BSA (2.5 μg), β-casein and RNase A or 10 μg of cardiac myofilament extract 26 was separated on a 1 mm, 12.5% polyacrylamide gel running at 150 V. Azo loading dye (2×) consisted of 100 μl Tris (1 M pH 6.8), 10 mg Azo, 200 μl bromophenol blue (0.04% solution), 200 μl glycerol, 20 μl DTT (1 M), and adjusted the volume to 1 ml with water. Azo running buffer was made using 1.5 g Tris-base, 7.2 g Glycine, 2.5 g Azo, and adjusted the volume to 1 l with water. The SDS-PAGE comparison gel was run using the same condition except 20 mg of SDS was used in the loading dye and 0.5 g of SDS was used in the running buffer. The methods described here correspond to data presented in Supplementary Fig. 3 .
UV-vis degradation. Azo (50 µl, 0.1%) in (1) H 2 O, (2) 1% formic acid, (3) IPA, (4) 1% formic acid in IPA, (5) 2-ME in H 2 O and (6) 1% formic acid in IPA:H 2 O were irradiated with a 100 W high-pressure mercury lamp (Nikon housing with Nikon HB-10101AF power supply; Nikon) for 0, 10, 30, 60, 90 and 120 s, respectively, in a quartz cuvette. The samples were diluted to a final volume of 1 ml in H 2 O. A UV-vis spectrum was taken from each sample with a Varian Cary 50 UV-Visible spectrophotometer (background correction, medium scan rate, 600-200 nm). The methods described here correspond to the data presented in Supplementary Fig. 4 .
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Evaluation of the effect of reducing agents during Azo degradation. Standard proteins, Ubi, RNase A, Cytc, and BSA were dissolved in 49.5:49.5:1 H 2 O:IPA:formic acid and kept on ice until analysis. Samples were irradiated with a 100 W lamp for 3 min. Sample (5 µl) was injected onto a trap column and eluted with 40:40:20 ACN:IPA:1% formic acid in H 2 O after a 5 min wash with 2.5:2.5:95 ACN:IPA:1% formic acid in H 2 O. DTT, TCEP and 2-ME (all 50 mM) were added to each Cytc sample before irradiation. Additionally, a sample of Cytc was kept at room temperature with no reducing agent and irradiated for 3 min with no reducing agent as a control (corresponding to Supplementary Figs. 6 and 7) . This method was repeated to test 10 mM TCEP and 33 mM methionine (corresponding to Supplementary Fig. 8 ).
Protein extraction and LC-MS analysis for evaluating the effect of Azo on relative quantitation. Ten volumes of buffer (10 mM Tris, 500 mM NaF, 2 mM EDTA, 1 mM PMSF, 1 mM Na 3 VO 4 , 5 mM DTT) was added to swine heart tissue. The sample was homogenized with Teflon homogenizer, centrifuged at 16,000g, and the supernatant was collected. Protein extract was diluted to a final buffer containing 25% IPA, 25% ACN, 1% formic acid, 100 mM TCEP and 5 mM NH 4 HCO 3 with or without 0.2% Azo. The sample was irradiated for 3 min and exchanged into a 10% ACN, 10% IPA, with 0.2% formic acid using a 10 kDa MWCO centrifugal filter. Proteins were separated using the following gradient: 0-5 min 20% B, 5-30 min 20-65% B, 30-35 min 65% B, 35-36 min 20% B, 36-40 min 20% B. Column temperature was 60 °C. The methods described here correspond to the data presented in Supplementary Fig. 9 .
Comparison of the top-down MS compatibility of Azo to a broader range of commonly used surfactants. Ubi was dissolved in buffer containing 75:10:5:10 methanol:H 2 O:formic acid:1% surfactant (MaSDeS, PM, RG, NS, SDS, Azo, OG, DDM, DGT) with 10 mM TCEP. The Azo sample was irradiated for 3 min. The acid-labile surfactants were incubated for 75 min (24 h for MaSDeS) at 37 °C. The samples were then directly injected into a 12 T Fourier transform ion cyclotron resonance (solariX) mass spectrometer (Bruker Daltonics) with a nano-ESI sprayer (TriVersa NanoMate; Advion Bioscience). A voltage of 1.4 kV versus the inlet was applied with 0.3 psi drying gas. Two hundred scans were averaged for each sample. The mass range was set from 600 to 2,000 m/z with a 512,000 word transient. The methods described here correspond to the data presented in Supplementary Fig. 11 .
Protein extraction for top-down LC-MS compatibility comparing Azo to
MaSDeS, PM, RG, SDS, OG, DDM and DGT. Swine cardiac tissue (83.3 mg) was homogenized in 1 ml of buffer (25 mM NH 4 HCO 3 , 1 mM TCEP, and 1 mM PMSF). After centrifugation at 16,000g, the supernatant was collected and the protein concentration was adjusted to 2 mg ml ), 25 µl isopropanol, 5 μl TCEP (100 mM) and 2.5 μl formic acid. The Azo sample was irradiated for 3 min. The acid cleavable surfactants PM 21 and RG 11 (also known as ALS 13 ) were incubated at 37 °C for 1 h while MaSDeS was incubated at 37 °C for 24 h because of its slow degradation 10 . All samples without or with the surfactants (MaSDeS, PM, RG, SDS, Azo, OG, DDM, DGT) were buffer-exchanged into 10% ACN, 10% IPA and 1% FA using a MWCO filter (3 × 100 μl) and adjusted to the original volume of 50 μl. Proteins were separated using the following gradient: 0-5 min, 20% B; 5-30 min, 20-65% B; 30-35 min, 65% B; 35-36 min, 20% B; 36-40 min, 20% B. Column temperature was 60 °C. The methods described here correspond to the data presented in Supplementary Fig. 12 .
Data analysis. Data were analyzed and processed in DataAnalysis 4.3 (Bruker Daltonics). An msalign file was created using the Sophisticated Numerical Annotation Procedure (SNAP) peak-picking algorithm with the following parameters: quality factor (0.4); signal-to-noise ratio (S/N) (3); intensity threshold (500); retention window (1.5 min). The file contained the following information: precursor mass, precursor charge, precursor mass followed by the fragment masses, intensities and charges. 31 was used to determine the subcellular locations of the identified proteins, which were then graphed in Microsoft Excel. String analysis software 32 was used to create an interactome map of identified proteins belonging to the electron transport chain.
The proteoform maps were generated as follows: (1) LC-MS scans were averaged every minute; (2) deconvoluted using maximum entropy algorithm (resolution: 80,000; mass range: 5,000-60,000 Da); (3) mass list outputs were generated using SNAP peak picking (quality factor: 0.8, S/N: 3, absolute intensity 1,000) as described previously 33 . A graphic map was then generated in Microsoft Excel based on the first retention time and the monoisotopic mass generated from SNAP. The methods described here correspond to the data presented in Supplementary Fig. 13 .
Statistical analysis.
For the protein solubility experiment (Fig. 1f) comparing Azo, SDS, DDM and MaSDeS, three independent protein assays (n = 3) were performed to evaluate surfactant performance. Error bars represent s.e.m. For the broader protein solubility comparison ( Supplementary Fig. 10 ), data presented were based on three independent experiments (n = 3). Error bars represent s.e.m. For LC-MS analysis ( Supplementary Fig. 9 ), three separate samples (n = 3) were prepared for each condition. Error bars represent standard error of the mean.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
data availability
All data generated or analyzed during this study are presented in this article or in the provided supplementary materials. Raw gel, blot and mass spectra data are available as Supplementary Data, and source data for Fig. 1 and Supplementary  Figs. 4 , 9, 10 and 13 are available online. Proteomics data have been uploaded to the PRIDE repository via ProteomeXchange with identifier PXD010825. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
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Data collection
Mass spectrometry data was collected using otofControl Version 4.3 (Build 60.11), ftmsControl 2.1.0, or LTQ FT Ultra 2.5. Protein assay data was generated using Gen5 reader control 2.05. UV-Vis collected on Varian Cary 50 UV-Visible spectrophotometer .
Data analysis
Mass spectrometry data was analyzed using DataAnalysis 4.3 (Build 110.102.1532) or Xcalibur. TopPIC v1.1.0 was used to determine protein and proteoform identifications. Mash Suite Pro v1.0.00.26946 and ProSight lite v1.4 were used for validation. Interactome analysis was performed using String Software V10.5. Plots were generated in Microsoft Excel 2016 and figures were made in Microsoft Powerpoint 2016.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Data Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
All data generated or analyzed during this study is presented in this manuscript or supplementary information with corresponding source data. Moreover, proteomics data has been uploaded to PRIDE repository via ProteomeXchange with identifier PXD010825.
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Sample size
The overall goal of the study is to demonstrate Azo's good protein solubility and MS-compatibility, which is demonstrated in multiple n=3 experiments. For the protein solubility experiment (Figure 1f) comparing Azo, SDS, DDM, and MaSDeS, three independent protein assays (n=3) were performed to evaluate surfactant performance. Error bars represent standard error of the mean. For the broader protein solubility comparison ( Supplementary Fig. 10 ), data presented were based on three independent experiments (n=3). Error bars represent standard error of the mean. For LC-MS analysis ( Supplementary Fig 9) , three separate samples (n=3) were prepared for each condition. Error bars represent standard error of the mean. Figure 13) , the following parameters were set in DataAnalysis: quality factor: 0.8, S/N: 3, absolute intensity: 1,000. Data that did not meet these requirements were excluded. This mitigated artifacts from the deconvolution algorithm or adducts (i.e. the addition of sodium from sample vials or lines) which would inflate the number of detected proteoforms. Moreover a quality factor of 0.8 helped ensure that only quality proteoform spectra were included in the count.
Data exclusions For the proteoform comparison (Supplementary
Replication
All attempts at replication were successful.
Randomization Randomization was not relevant to this study as no biological comparisons were made. Qualitative assessment of surfactant extraction and mass spectrometry performance are not time or sample order dependent. All comparisons were performed side-by-side using the same extraction conditions.
Blinding
Blinding was not relevant to this study as no biological comparisons or correlations were made. Additionally, different surfactants required different workups (e.g. acid or UV); therefore a blind test was not applicable.
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